Cargando…
Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya
BACKGROUND: Due to widespread anti-malarial drug resistance in many countries, Kenya included, artemisinin-based Combination Therapy (ACT) has been adopted as the most effective treatment option against malaria. Artemether-lumefantrine (AL) is the first-line ACT for treatment of uncomplicated malari...
Autores principales: | Watsierah, Carren A, Onyango, Rosebella O, Ombaka, James H, Abong’o, Benard O, Ouma, Collins |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544597/ https://www.ncbi.nlm.nih.gov/pubmed/23273046 http://dx.doi.org/10.1186/1475-2875-11-436 |
Ejemplares similares
-
Factors determining anti-malarial drug use in a peri-urban population from malaria holoendemic region of western kenya
por: Watsierah, Carren A, et al.
Publicado: (2010) -
Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya
por: Watsierah, Carren A, et al.
Publicado: (2011) -
Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya
por: Watsierah, Carren A, et al.
Publicado: (2014) -
Quinine plus clindamycin vs artemether-lumefantrine for treatment of uncomplicated falciparum malaria in western Kenya
por: Obonyo, Charles O., et al.
Publicado: (2022) -
Community health worker interventions are key to optimal infant immunization coverage, evidence from a pretest-posttest experiment in Mwingi, Kenya
por: Nzioki, Japheth Mativo, et al.
Publicado: (2017)